VFM
AMED

Vivid Financial Management’s Amedisys AMED Stock Holding History

Vivid Financial Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,637
Closed -$480K – 147
2020
Q4 		$480K Sell
1,637
-356
-18% -$91.3K 0.23% 70
2020
Q3 		$471K Buy
+1,993
New +$453K 0.29% 49

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vivid Financial Management's AMED Position: Q1 2021 in Review

Vivid Financial Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 1,637 shares — an estimated $480K sold.

Vivid Financial Management first reported a position in AMED in Q3 2020 and held it in 2 quarters. The position peaked at $480K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Vivid Financial Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Vivid Financial Management sold 1,637 Amedisys shares in Q1 2021, an estimated $480K.
  • Vivid Financial Management first reported a position in Amedisys in Q3 2020 and held it in 2 quarters.
  • Vivid Financial Management's Amedisys position peaked at $480K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Vivid Financial Management's 13F filing for Q1 2021, filed 14 Apr 2021.